1. Home
  2. CRGX vs FFWM Comparison

CRGX vs FFWM Comparison

Compare CRGX & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FFWM
  • Stock Information
  • Founded
  • CRGX 2021
  • FFWM 1990
  • Country
  • CRGX United States
  • FFWM United States
  • Employees
  • CRGX 170
  • FFWM N/A
  • Industry
  • CRGX
  • FFWM Major Banks
  • Sector
  • CRGX
  • FFWM Finance
  • Exchange
  • CRGX Nasdaq
  • FFWM Nasdaq
  • Market Cap
  • CRGX 621.4M
  • FFWM 630.9M
  • IPO Year
  • CRGX 2023
  • FFWM 2014
  • Fundamental
  • Price
  • CRGX $13.44
  • FFWM $5.66
  • Analyst Decision
  • CRGX Strong Buy
  • FFWM Buy
  • Analyst Count
  • CRGX 6
  • FFWM 4
  • Target Price
  • CRGX $31.80
  • FFWM $6.75
  • AVG Volume (30 Days)
  • CRGX 298.6K
  • FFWM 522.0K
  • Earning Date
  • CRGX 11-12-2024
  • FFWM 01-30-2025
  • Dividend Yield
  • CRGX N/A
  • FFWM 0.35%
  • EPS Growth
  • CRGX N/A
  • FFWM N/A
  • EPS
  • CRGX N/A
  • FFWM N/A
  • Revenue
  • CRGX N/A
  • FFWM $108,182,000.00
  • Revenue This Year
  • CRGX N/A
  • FFWM N/A
  • Revenue Next Year
  • CRGX N/A
  • FFWM $31.36
  • P/E Ratio
  • CRGX N/A
  • FFWM N/A
  • Revenue Growth
  • CRGX N/A
  • FFWM N/A
  • 52 Week Low
  • CRGX $12.17
  • FFWM $4.84
  • 52 Week High
  • CRGX $33.92
  • FFWM $11.47
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 40.40
  • FFWM 29.39
  • Support Level
  • CRGX $13.65
  • FFWM $5.74
  • Resistance Level
  • CRGX $15.75
  • FFWM $6.42
  • Average True Range (ATR)
  • CRGX 1.20
  • FFWM 0.33
  • MACD
  • CRGX 0.10
  • FFWM -0.01
  • Stochastic Oscillator
  • CRGX 37.57
  • FFWM 9.43

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

Share on Social Networks: